A Prospective Study to Investigate Safety and Tolerability of Shorter Infusion of Fabrazyme

Clinical trial NCT06019728 · COMPLETED

Trial details

NCT number: NCT06019728
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Fabry's Disease

Start date: 2023-11-10
Primary completion: 2024-10-25
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.